SCHEMBL4038273

SCHEMBL4038273

CC(=O)N1CCN(CCOc2ccc(NC(=O)COc3cccc(C)c3)cc2-c2ccnn2C)CC1

nearest known ligand 0.70

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 19/20 0.70
HTR2C P28335 13/20 0.66
KCNH2 Q12809 2/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3952977 0.92 HTR2A (0.79) HTR2AHTR2CKCNH2
SCHEMBL14385356 0.92 HTR2A (0.69) HTR2AHTR2C
SCHEMBL3948999 0.92 HTR2A (0.72) HTR2AHTR2CKCNH2
SCHEMBL3948265 0.92 HTR2A (0.77) HTR2AHTR2CKCNH2
SCHEMBL14384636 0.91 HTR2A (0.71) HTR2AHTR2C
SCHEMBL3944669 0.91 HTR2A (0.69) HTR2AHTR2CKCNH2
SCHEMBL3955875 0.91 HTR2A (0.69) HTR2AHTR2CKCNH2
SCHEMBL4045042 0.90 HTR2A (0.78) HTR2AHTR2CKCNH2
SCHEMBL14385334 0.88 HTR2A (0.67) HTR2AHTR2CKCNH2
SCHEMBL3954217 0.88 HTR2A (0.73) HTR2AHTR2CKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2051978-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-04-29 EP claimed
WO-2007136875-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-11-29 WO claimed
EP-2051978-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-04-29 EP disclosed
WO-2007136875-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-11-29 WO disclosed